Company Filing History:
Years Active: 2006-2007
Title: Shmuel Zbaida: Innovator in Pharmaceutical Development
Introduction
Shmuel Zbaida is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various medical conditions. With a total of 3 patents to his name, Zbaida's work has the potential to impact many lives.
Latest Patents
Zbaida's latest patents include a metabolite of a xanthine Phosphodiesterase 5 inhibitor and derivatives thereof, which are useful for the treatment of erectile dysfunction. This invention is directed towards a metabolite that has a specific structure and formulations, along with processes for preparing the same. The patent also discloses methods for treating a range of physiological disorders, including urogenital, cardiovascular, and cerebrovascular disorders, among others.
Another significant patent involves metabolites of tricyclic amides that are useful for inhibiting G-protein function. This invention relates to methods for treating proliferative diseases and inhibiting abnormal cell growth, showcasing Zbaida's innovative approach to addressing complex health issues.
Career Highlights
Shmuel Zbaida is currently associated with Schering Corporation, where he continues to contribute to pharmaceutical research and development. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Zbaida has collaborated with notable colleagues, including Anima Ghosal and Swapan K Chowdhury. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Shmuel Zbaida's contributions to pharmaceutical innovation are noteworthy, with a focus on developing treatments for various medical conditions. His patents reflect a deep understanding of complex biological systems and a commitment to improving health outcomes.